| 720 |
Centers for Disease Control and Prevention |
Html |
en |
World AIDS Day - December 1, 2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.66474 |
| Human Services | 0.90694 |
| assistive technology | 0.668078 |
| Joint United Nations | 0.999607 |
| U.S. Department | 0.758546 |
| MMWR HTML versions | 0.75543 |
| AIDS Relief | 0.653205 |
| electronic PDF version | 0.741115 |
| global AIDS epidemic | 0.783027 |
| Emergency Plan | 0.648279 |
| Global report | 0.654469 |
| middle-income countries | 0.657683 |
| epidemic worldwide | 0.666742 |
| Contact GPO | 0.661343 |
| commercial sources | 0.638634 |
| World AIDS | 0.668071 |
| current prices | 0.637986 |
| persons | 0.650156 |
| U.S. dependent areas—2010 | 0.774847 |
| original paper copy | 0.747041 |
| surveillance supplemental report | 0.778527 |
| Global efforts | 0.64405 |
| care objectives | 0.638263 |
| human immunodeficiency | 0.686309 |
|
| Shared Responsibility | 0.650596 |
| AIDS diagnoses | 0.663741 |
| United States | 0.652498 |
| CDC. Monitoring | 0.643379 |
| U.S. Government Printing | 0.762265 |
| original MMWR paper | 0.751126 |
| antiretroviral therapy | 0.657418 |
| U.S. President | 0.652887 |
| Strengthening Results | 0.653727 |
| MMWR readers | 0.647878 |
| character translation | 0.632646 |
| HIV surveillance report | 0.845521 |
| national HIV prevention | 0.821851 |
| immunodeficiency syndrome | 0.678829 |
| HIV surveillance | 0.925813 |
| format errors | 0.632221 |
| current status | 0.658365 |
| UNAIDS report | 0.706724 |
| United Nations Programme | 0.999496 |
| subject line | 0.664734 |
| typeset documents | 0.638732 |
| trade names | 0.638727 |
| non-CDC sites | 0.636909 |
| AIDS-Free Generation | 0.653864 |
|
CLICK HERE |
| 1011 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: Updated Guidelines on Managing DrugInteractions in the Treatment of HIV-Related Tuberculosis |
Guidelines for managing pharmacologic interactions that can result when patients receive antiretroviral drugs for treatment of human immunodeficiency virus (HIV) infection together with rifamycin antibiotics for treatment of tuberculosis (TB) have been published previously (1–4). Newly updated guidelines, developed by CDC in collaboration with experts from other key national and international institutions, are now available at http://www.cdc. |
| latent TB infection | 0.797716 |
| online guidelines | 0.583453 |
| pharmacokinetic data | 0.582676 |
| endorsement | 0.485791 |
| additional recommendations | 0.58107 |
| Human Services | 0.705094 |
| latest information | 0.563705 |
| U.S. Department | 0.70552 |
| MMWR HTML versions | 0.691045 |
| Newly updated guidelines | 0.764533 |
| pregnant women | 0.566426 |
| electronic PDF version | 0.676732 |
| special populations | 0.564704 |
| young children | 0.565898 |
| integrase inhibitors | 0.57837 |
| Contact GPO | 0.590737 |
| patients | 0.456114 |
| commercial sources | 0.562289 |
| current prices | 0.553473 |
| new classes | 0.576329 |
| specific antiretroviral regimens | 0.938608 |
| original paper copy | 0.671566 |
| clinical experience | 0.685522 |
| human immunodeficiency virus | 0.753453 |
|
| antiretroviral drugs | 0.910693 |
| drug-resistant TB | 0.664991 |
| pharmacologic interactions | 0.596 |
| new guidelines | 0.594589 |
| antiretroviral therapy | 0.727316 |
| original MMWR paper | 0.683987 |
| U.S. Government Printing | 0.675466 |
| rifabutin | 0.444818 |
| international institutions | 0.583989 |
| MMWR readers | 0.568012 |
| character translation | 0.552373 |
| newer antiretroviral drugs | 0.879481 |
| format errors | 0.55579 |
| TB treatment | 0.658395 |
| rifamycin antibiotics | 0.591771 |
| New features | 0.572378 |
| Health | 0.450891 |
| typeset documents | 0.562811 |
| trade names | 0.562424 |
| official text | 0.550056 |
| CCR5 receptor antagonists | 0.741922 |
| non-CDC sites | 0.55996 |
| key antiretroviral regimens | 0.935141 |
| electronic conversions | 0.550725 |
|
CLICK HERE |
| 5813 |
Centers for Disease Control and Prevention |
Html |
en |
Lead - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5838 |
Centers for Disease Control and Prevention |
Html |
en |
Mica (containing less than 1% quartz) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7174 |
Centers for Disease Control and Prevention |
Html |
en |
Previous HIV Testing Among Adults and Adolescents Newly Diagnosed with HIV Infection - National HIV Surveillance System, 18 Jurisdictions, United States, 2006-2009 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| positive HIV antibody | 0.201844 |
| negative HIV tests | 0.220507 |
| HIV antibody test | 0.292487 |
| new HIV infections | 0.215029 |
| recent HIV test | 0.217112 |
| national HIV incidence | 0.245107 |
| intensified HIV prevention | 0.209492 |
| HIV testing strategies | 0.252701 |
| HIV incidence surveillance | 0.371112 |
| negative HIV test | 0.866415 |
| HIV diagnosis | 0.605852 |
| hiv surveillance | 0.237628 |
| HIV infection* | 0.221502 |
| negative HIV antibody | 0.279027 |
| HIV transmission | 0.342292 |
| HIV transmission category | 0.221708 |
| positive HIV test | 0.209276 |
|
| recent negative HIV | 0.309204 |
| HIV prevention efforts | 0.249134 |
| HIV test result | 0.249569 |
| positive HIV | 0.210627 |
| HIV surveillance data | 0.214176 |
| persons | 0.24384 |
| HIV screening | 0.217051 |
| HIV | 0.960273 |
| previous HIV testing | 0.276128 |
| previous negative HIV | 0.358573 |
| high risk | 0.273105 |
| HIV testing | 0.40009 |
| previous HIV test | 0.230045 |
| HIV testing patterns | 0.318155 |
| HIV infection | 0.928065 |
| HIV incidence estimate | 0.246237 |
|
CLICK HERE |
| 10939 |
Centers for Disease Control and Prevention |
Html |
en |
Should I Get Screened for Prostate Cancer? |
CDC and other federal agencies follow the prostate cancer screening recommendations set forth by the U.S. Preventive Services Task Force, which recommends against PSA-based screening for men who do not have symptoms. |
| abnormal results | 0.764558 |
| prostate cells | 0.647202 |
| infection | 0.431069 |
| CDC | 0.490571 |
| bleeding | 0.436471 |
| Force | 0.434412 |
| Physicians | 0.431815 |
| false negative results | 0.725839 |
| abnormal result | 0.611705 |
| recommendations | 0.477829 |
| right decision | 0.578356 |
| American Cancer Society | 0.722577 |
| men | 0.534685 |
| American Urological Association | 0.735629 |
| federal agencies | 0.59959 |
| Preventive Services Task | 0.76553 |
|
| tissues | 0.436748 |
| minor surgery | 0.563017 |
| prostate specific antigen | 0.876325 |
| man— | 0.428735 |
| -based screening | 0.639876 |
| symptoms | 0.434101 |
| anxiety | 0.432142 |
| prostate cancer | 0.953809 |
| PSA test | 0.955098 |
| theU.S | 0.434784 |
| tests | 0.430299 |
| doctors | 0.429044 |
| decision making | 0.696349 |
| organizations | 0.432077 |
| College | 0.431846 |
|
CLICK HERE |
| 11686 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Telebriefing: CDC update on first Ebola case diagnosed in the United States, 10-05-2014 | Transcript | CDC Newsroom | CDC |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| ePub file | 0.621383 |
| Fear Act | 0.520632 |
| Email | 0.249631 |
| Policies | 0.246206 |
| Funding | 0.276355 |
| SEARCH | 0.255992 |
| Tweet | 0.341409 |
| MENU
CDC A-Z | 0.931048 |
|
| Human Services | 0.474691 |
| OIG | 0.357645 |
| U.S. Department | 0.477042 |
| Privacy | 0.283031 |
| RSS | 0.282873 |
| YouTube
Instagram | 0.568104 |
| Jobs | 0.247014 |
|
CLICK HERE |
| 11841 |
Centers for Disease Control and Prevention |
Html |
null |
Get Smart | Print Products | Antibiotic Week |
Get Smart About Antibiotics Week's print products and patient education on antibiotics.
|
|
|
CLICK HERE |
| 13708 |
Centers for Disease Control and Prevention |
Html |
en |
7 in 10 students who currently use tobacco used a flavored product | CDC Online Newsroom |
CDC public health news, press releases, government public health news, medical and disease news, story ideas, photos. |
| Mortality Weekly Report | 0.411896 |
| nicotine addiction | 0.355461 |
| deputy director | 0.349575 |
| lower prevalence | 0.349757 |
| nation’s youth | 0.351885 |
| America’s youth | 0.356363 |
| New York City | 0.392164 |
| public education media | 0.391319 |
| tobacco control programs | 0.499698 |
| Disease Control | 0.358899 |
| Youth Tobacco Survey | 0.549798 |
| CDC’s Office | 0.353124 |
| flavored e-cigarettes | 0.468896 |
| flavored e-cigarette | 0.493872 |
| current users | 0.359037 |
| U.S. youth | 0.350035 |
| hookah tobacco | 0.504844 |
| Director Tom Frieden | 0.400237 |
| Brian King | 0.350632 |
| following  tobacco products | 0.55342 |
| tobacco products | 0.963494 |
| flavored cigar | 0.492323 |
| U.S. middle | 0.35932 |
| greater proportion | 0.360286 |
| Drug Administration | 0.361376 |
|
| comprehensive smoke-free laws | 0.392784 |
| percent | 0.606708 |
| Santa Clara | 0.349526 |
| early death | 0.353899 |
| flavored tobacco | 0.997595 |
| non-Hispanic blacks | 0.425573 |
| tobacco-related disease | 0.354448 |
| Additional strategies | 0.35016 |
| menthol cigarette | 0.368131 |
| non-Hispanic whites | 0.422704 |
| Rhode Island | 0.348826 |
| middle school students | 0.40004 |
| nicotine dependence | 0.357103 |
| research translation | 0.350549 |
| flavored product | 0.511621 |
| high school students | 0.595616 |
| local jurisdictions | 0.35089 |
| flavored tobacco product | 0.758145 |
| smokeless tobacco | 0.594916 |
| higher proportion | 0.358989 |
| menthol cigarettes | 0.433003 |
| non-flavored tobacco products | 0.535948 |
| new generation | 0.352945 |
| flavored tobacco products | 0.932652 |
|
CLICK HERE |
| 15495 |
Centers for Disease Control and Prevention |
Html |
en |
Youth Risk Behavior Surveillance - United States, 2015 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| 11th-grade female | 0.289414 |
| data | 0.270606 |
| standard questionnaire | 0.272894 |
| 12th-grade male | 0.358019 |
| school district surveys | 0.300832 |
| priority health behaviors | 0.287405 |
| urban school districts | 0.737908 |
| Youth Risk Behavior | 0.350811 |
| school property | 0.408176 |
| 10th-grade male | 0.324657 |
| health behaviors | 0.320187 |
| Hispanic male | 0.341259 |
| 9th-grade male | 0.318679 |
| bicycle helmet | 0.283184 |
| white female | 0.284716 |
| Hispanic female | 0.295549 |
| median | 0.285032 |
| survey | 0.31385 |
| long-term temporal trends | 0.269469 |
| school district youth | 0.250437 |
| significant quadratic trend | 0.425522 |
| male | 0.482363 |
| large urban school | 0.916678 |
| United States | 0.280258 |
| students | 0.741386 |
|
| 11th-grade male | 0.337941 |
| white male | 0.372075 |
| states | 0.329048 |
| prevalence estimates | 0.271133 |
| response options | 0.250217 |
| prevalence | 0.544116 |
| Hispanic students | 0.25877 |
| 10th-grade female | 0.282971 |
| urban school district | 0.466051 |
| significant linear decrease | 0.37032 |
| private¶ school students | 0.25137 |
| Table | 0.296649 |
| national YRBS | 0.331635 |
| response rates | 0.256072 |
| national YRBS prevalence | 0.258931 |
| high school students | 0.321955 |
| safety concerns | 0.279745 |
| black male | 0.350527 |
| physical fight | 0.394458 |
| black female | 0.277334 |
| seat belt | 0.258479 |
| 12th-grade female | 0.345099 |
| school enrollment size | 0.256959 |
| Risk Behavior Surveillance | 0.283509 |
|
CLICK HERE |